Literature DB >> 20136693

Oestrogen receptors enhance dopamine neurone survival in rat midbrain.

M L Johnson1, C C Ho, A E Day, Q D Walker, R Francis, C M Kuhn.   

Abstract

Previous findings in our laboratory and elsewhere have shown that ovariectomy of rats in adulthood attenuates cocaine-stimulated locomotor behaviour. Ovarian hormones enhance both cocaine-stimulated behaviour and increase dopamine overflow after psychomotor stimulants. The present study aimed to determine whether ovarian hormones have these effects in part by maintaining dopamine neurone number in the substantia nigra pars compacta (SNpc) and ventral tegmental area (VTA) and to investigate the roles of specific oestrogen receptors (ERs) in the maintenance of mesencephalic dopamine neurones. To accomplish this goal, we used unbiased stereological techniques to estimate the number of tyrosine hydroxylase-immunoreactive (TH-IR) cell bodies in midbrain regions of intact, ovariectomised and hormone-replaced female rats and mice. Animals received active or sham gonadectomy on postnatal day 60 and received vehicle, 17beta-oestradiol (E(2)) or selective ER agonists propyl-pyrazole-triol (PPT, ERalpha) or diarylpropionitrile (DPN, ERbeta) for 1 month post-surgery. In both rats and mice, ovariectomy reduced the number of TH-IR cells in the SNpc and VTA. Replacement with E(2), PPT or DPN prevented or attenuated the loss observed with ovariectomy in both rats and mice. An additional study using ER knockout mice revealed that adult female mice lacking ERalpha had fewer TH-IR cells in midbrain regions than wild-type mice, whereas mice lacking ERbeta had TH-IR cell counts comparable to wild-type. These findings suggest that, although both ER subtypes play a role in the maintenance of TH-IR cell number in the SNpc and VTA, ERalpha may play a more significant role.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20136693      PMCID: PMC3019761          DOI: 10.1111/j.1365-2826.2010.01964.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  66 in total

1.  Effects of sex and hormonal status on astrocytic basic fibroblast growth factor-2 and tyrosine hydroxylase immunoreactivity after medial forebrain bundle 6-hydroxydopamine lesions of the midbrain dopamine neurons.

Authors:  I A Moroz; H Rajabi; D Rodaros; J Stewart
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

2.  ERbeta mediates the estradiol increase of D2 receptors in rat striatum and nucleus accumbens.

Authors:  Maryvonne Le Saux; Marc Morissette; Thérèse Di Paolo
Journal:  Neuropharmacology       Date:  2005-11-23       Impact factor: 5.250

3.  Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.

Authors:  S Jourdain; M Morissette; N Morin; T Di Paolo
Journal:  J Neuroendocrinol       Date:  2005-08       Impact factor: 3.627

4.  Estrogen provides neuroprotection against activated microglia-induced dopaminergic neuronal injury through both estrogen receptor-alpha and estrogen receptor-beta in microglia.

Authors:  Xuan Liu; Xiao-Lan Fan; Yan Zhao; Guang-Rui Luo; Xu-Ping Li; Rui Li; Wei-Dong Le
Journal:  J Neurosci Res       Date:  2005-09-01       Impact factor: 4.164

Review 5.  Sex differences in vulnerability to drug self-administration.

Authors:  Wendy J Lynch
Journal:  Exp Clin Psychopharmacol       Date:  2006-02       Impact factor: 3.157

Review 6.  Neuroprotection by ovarian hormones in animal models of neurological disease.

Authors:  Gloria E Hoffman; Istvan Merchenthaler; Susan L Zup
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

7.  Influence of oestrogenic compounds on monoamine transporters in rat striatum.

Authors:  M Le Saux; T Di Paolo
Journal:  J Neuroendocrinol       Date:  2006-01       Impact factor: 3.627

8.  Sex differences in neurochemical effects of dopaminergic drugs in rat striatum.

Authors:  Q David Walker; Rupa Ray; Cynthia M Kuhn
Journal:  Neuropsychopharmacology       Date:  2006-06       Impact factor: 7.853

9.  Age and gender differences in behavioral and morphological outcome after 6-hydroxydopamine-induced lesion of the substantia nigra in rats.

Authors:  Andrea Tamás; Andrea Lubics; Luca Szalontay; István Lengvári; Dóra Reglodi
Journal:  Behav Brain Res       Date:  2005-03-30       Impact factor: 3.332

10.  Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha.

Authors:  Sudha Warrier Mitra; Elena Hoskin; Joel Yudkovitz; Lisset Pear; Hilary A Wilkinson; Shinji Hayashi; Donald W Pfaff; Sonoko Ogawa; Susan P Rohrer; James M Schaeffer; Bruce S McEwen; Stephen E Alves
Journal:  Endocrinology       Date:  2003-05       Impact factor: 4.736

View more
  27 in total

Review 1.  Emergence of sex differences in the development of substance use and abuse during adolescence.

Authors:  Cynthia Kuhn
Journal:  Pharmacol Ther       Date:  2015-06-03       Impact factor: 12.310

2.  Normal midbrain dopaminergic neuron development and function in miR-133b mutant mice.

Authors:  Mary P Heyer; Amar K Pani; Richard J Smeyne; Paul J Kenny; Guoping Feng
Journal:  J Neurosci       Date:  2012-08-08       Impact factor: 6.167

3.  Sex differences and effects of prenatal exposure to excess testosterone on ventral tegmental area dopamine neurons in adult sheep.

Authors:  Erinna C Z Brown; Casey J Steadman; Theresa M Lee; Vasantha Padmanabhan; Michael N Lehman; Lique M Coolen
Journal:  Eur J Neurosci       Date:  2015-03-18       Impact factor: 3.386

4.  Effect of different doses of estrogen on the nigrostriatal dopaminergic system in two 6-hydroxydopamine-induced lesion models of Parkinson's disease.

Authors:  Marcela Ferreira Cordellini; Giovana Piazzetta; Karin Cristine Pinto; Ana Márcia Delattre; Francesca Matheussi; Ruither O G Carolino; Raphael Escorsim Szawka; Janete A Anselmo-Franci; Anete Curte Ferraz
Journal:  Neurochem Res       Date:  2011-02-24       Impact factor: 3.996

5.  Gender-specific roles for the melanocortin-3 receptor in the regulation of the mesolimbic dopamine system in mice.

Authors:  Rachel N Lippert; Kate L J Ellacott; Roger D Cone
Journal:  Endocrinology       Date:  2014-02-26       Impact factor: 4.736

6.  Individual differences in psychostimulant responses of female rats are associated with ovarian hormones and dopamine neuroanatomy.

Authors:  Q David Walker; Misha L Johnson; Amanda E D Van Swearingen; Andrew E Arrant; Joseph M Caster; Cynthia M Kuhn
Journal:  Neuropharmacology       Date:  2012-02-08       Impact factor: 5.250

Review 7.  Sex-dependent effects of nicotine on the developing brain.

Authors:  Sarah J Cross; Kay E Linker; Frances M Leslie
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 8.  The emergence of gonadal hormone influences on dopaminergic function during puberty.

Authors:  Cynthia Kuhn; Misha Johnson; Alex Thomae; Brooke Luo; Sidney A Simon; Guiying Zhou; Q David Walker
Journal:  Horm Behav       Date:  2009-11-10       Impact factor: 3.587

Review 9.  The Role of Sex and Sex Hormones in Neurodegenerative Diseases.

Authors:  Elisabetta Vegeto; Alessandro Villa; Sara Della Torre; Valeria Crippa; Paola Rusmini; Riccardo Cristofani; Mariarita Galbiati; Adriana Maggi; Angelo Poletti
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

10.  Estradiol replacement enhances cocaine-stimulated locomotion in female C57BL/6 mice through estrogen receptor alpha.

Authors:  Amanda E D Van Swearingen; Cristina L Sanchez; Suzanne M Frisbee; Antonia Williams; Q David Walker; Kenneth S Korach; Cynthia M Kuhn
Journal:  Neuropharmacology       Date:  2013-04-19       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.